Completed

Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Mirror therapy

+ Divider therapy

Behavioral
Who is being recruted

Brain Diseases+8

+ Cardiovascular Diseases

+ Central Nervous System Diseases

From 21 to 85 Years
+6 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: September 2012
See protocol details

Summary

Principal SponsorAlbert Einstein Healthcare Network
Last updated: June 30, 2020
Sourced from a government-validated database.Claim as a partner

Study start date: September 7, 2012

Actual date on which the first participant was enrolled.

This study will compare two forms of home-based treatment for post-stroke problems making movements with the arms and hands. After initial pre-treatment assessments, participants will complete 4 weeks of treatment, with assessments after each week of treatment and 3 months after the completion of treatment.

NCT01662960
Principal SponsorAlbert Einstein Healthcare Network
Last updated: June 30, 2020
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

72 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 21 to 85 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Brain DiseasesCardiovascular DiseasesCentral Nervous System DiseasesCerebrovascular DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsVascular DiseasesParesisStroke

Criteria

4 inclusion criteria required to participate
6 months or more post-stroke
no longer participating in upper-extremity physical or occupational therapy
sufficient comprehension ability to understand instructions
upper extremity Fugl-Meyer score between 10 and 50
2 exclusion criteria prevent from participating
dementia
previous head trauma, psychiatric illness or chronic exposure to medications that might be expected to have lasting consequences for the central nervous system (e.g., haloperidol, dopaminergics)

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
4 weeks of home-based mirror therapy. Participants practiced making movements with mirrored visual feedback of the low-functioning arm.

Group II

Active Comparator
4 weeks of home-based divider therapy (control therapy to mirror therapy; mirror replaced by a divider). Participants practiced making movements with no visual feedback of the low-functioning arm.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Einstein Medical Center Elkins Park

Elkins Park, United StatesOpen Einstein Medical Center Elkins Park in Google Maps
CompletedOne Study Center